Figures computed from official regulatory filings — .
Analysttarget 10 USD (+2073%)
Ownershipinsiders 8.02% · institutions 9.93% · short 0.9% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for MUSTANG BIO, INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children's hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
22 buys12 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Litchman Manuel MDtrack record | Other | $14.3 | SEC |
| CORONADO BIOSCIENCES INC | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Jin David | Buy | $237.1 | conv 65First in 12mo | SEC |
| Herskowitz Neiltrack record | Sell | $237.1 | SEC |
| Chill Adam J. | Sell | $3.8 | SEC |
| CORONADO BIOSCIENCES INC | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Litchman Manuel MDtrack record | Other | $33.5 | SEC |
| CORONADO BIOSCIENCES INC | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| CORONADO BIOSCIENCES INC | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Litchman Manuel MDtrack record | Other | $488.6 | SEC |
| Litchman Manuel MDtrack record | Other | $15.2K | SEC |
| Litchman Manuel MDtrack record | Other | $6.6K | SEC |
| CORONADO BIOSCIENCES INC | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Litchman Manuel MDtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| WEISS MICHAEL Strack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Herskowitz Neiltrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| ROSENWALD LINDSAY A MDtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| ZELEFSKY MICHAEL J | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Chill Adam J. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| ROSENWALD LINDSAY A MDtrack record | Buy | $2.6K | conv 34 | SEC |
| Litchman Manuel MDtrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Chill Adam J. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Litchman Manuel MDtrack record | Buy | $3.7K | conv 37 | SEC |
| WEISS MICHAEL Strack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| ZELEFSKY MICHAEL J | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |